Work Productivity and Activity Impairment of Caregivers of Huntington's Disease Patients in the US and EU5: Evidence from the Huntington's Disease Burden of Illness Study (HDBOI)

Author(s)

Willock R1, Frank S2, Stanley C3, Arnesen A4, Fuller R5, Rodriguez Santana I6, Ruiz L7, Doherty M8, Dolmetsch R9, Li N9, Ratsch S9, Ali TM9
1HCD Economics, Daresbury, CHW, UK, 2Harvard Medical School, Boston, MA, USA, 3Huntington's Disease Association, Liverpool, UK, 4European Huntington Association, Søgne, Norway, 5CHDI Management/CHDI Foundation, Princeton, NJ, USA, 6HCD Economics, Daresbury, Warrington, WRT, UK, 7HCD Economics, Daresbury, UK, 8HCD Economics, Daresbury, Warrington , UK, 9uniQure Inc, Lexington, MA, USA

OBJECTIVES

Huntington’s Disease (HD) is a rare, neuro-degenerative disorder with patients experiencing long term disability due to their condition. HD patients universally require caregiver support during their lifetime which is often associated with a large caregiver burden. This research explores the burden associated to caregiving by means of a set of questions, including the Work Productivity and Activity Impairment (WPAI) tool, and descriptively explores differences by disease stage.

METHODS

The HDBOI is a retrospective, cross-sectional dataset that captures patient information, medical resource, quality of life and WPAI of a cohort of HD patients and caregivers in Germany, France, Italy, Spain, UK and US. The WPAI-HD-Caregiver is a 6-item instrument which measures work time missed, impaired productivity at work, and impairment in daily activities (0% -100%) experienced by the caregiver of HD patient during the previous seven days.

RESULTS

The analytic sample is comprised of 503 HD caregivers who completed the WPAI, of which 35% were caregivers of early-stage (ES), 36% of mid stage (MS) and 29% of advanced stage patients (AS). The partner/spouse was the main caregiver (48%), followed by a parent (19%).

Overall impairment in caregiver daily activities increased with disease severity: 42% in ES, 48% in MS and 52% in AS. Likewise, for caregivers who reported being employed for pay (n=333), overall impaired productivity at work increased with disease severity: 42% in ES, 52% in MS and 54% in AS. A total of 37 respondents had to stop working because of their caregiving duties and 206 reported that their duties have impacted their career. Of the 206, 59% are prevented from working more hours, 54% prevented from career progression and 19% required to choose an alternate career.

CONCLUSIONS

Results from the HDBOI study show a significant work productivity impact on caregivers of HD patients which increases as disease progresses.

Conference/Value in Health Info

2021-11, ISPOR Europe 2021, Copenhagen, Denmark

Value in Health, Volume 24, Issue 12, S2 (December 2021)

Code

POSA140

Topic

Economic Evaluation, Methodological & Statistical Research

Topic Subcategory

PRO & Related Methods, Work & Home Productivity - Indirect Costs

Disease

Musculoskeletal Disorders, Neurological Disorders, Rare and Orphan Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×